MabSelect SuRe 70 and MabSelect PrismA X resins to set new standards in affordability and productivity Cytiva’s expanded resin portfolio will support advances in the mAb and biosimilar markets MabSelect… Read More
A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumours in chicken eggs and analyzing their proteins. The team,… Read More
Augurex is featured in a RheumNow Therapeutic Update with Dr. Walter Maksymowych, highlighting the role of 14-3-3eta across the RA care continuum. In this feature, Dr. Walter Maksymowych explores how… Read More
HEALWELL has acquired Auckland, New Zealand-based Orion Health Holdings Limited (“Orion Health”), a global healthcare intelligence platform providing subscription licenses and services to marquee public sector clients with data interoperability… Read More
OTTAWA, ON – Quebec signed a bilateral agreement under the federal government’s National Strategy for Drugs for Rare Diseases, making it the final jurisdiction to do so. With all provinces… Read More
